CSC - CAMS/PUMC - Oxford High-level Innovative Talent Scholarships
The Chinese Scholarship Council, Chinese Academy of Medical Sciences/Peking Union Medical College and the University of Oxford collaborate together for a programme of scholarship cooperation.
The main purpose of this programme is to train the next generation of leaders in the medical sciences field. By combining the strength of our partners, it is aimed at students with a clinical background with an interest in pursuing research in a scientific field related to medicine.
COVID Without Borders- A collaboration to Investigate A New Disease III – Vaccine Research and Development
18 December 2020
The webinar entitled “COVID Without Borders-A collaboration to Investigate A New Disease III – Diagnostic and Treatment for COVID-19” was held online on the morning of November 17th 2020, jointly organized by Chinese Academy of Medical Sciences (CAMS) and CAMS-Oxford Institute (COI).
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
COVID Without Borders - A collaboration to Investigate a New Disease II – Vaccine Research and Development
15 October 2020
The webinar entitled “COVID Without Borders - A collaboration to Investigate a New Disease II - Vaccine Research and Development” was held online on 22nd September 2020.
21 July 2020
On the morning of 1st July 2020, the webinar “COVID Without Borders – A collaboration to Investigate A New Disease” was held online. It was jointly organised by the Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College and CAMS-Oxford Institute (COI).
Hypoxic and pharmacological activation of HIFs inhibits SARS-CoV-2 infection of lung epithelial cells
MCKEATING J. et al, (2021), Cell Reports
Higgs DR., (2021), Nat Genet
Renner M. et al, (2021), Nat Commun, 12
The antigenic anatomy of SARS-CoV-2 receptor binding domain
GUPTA S. et al, (2021), Cell
Navarro-Guerrero E. et al, (2021), Sci Rep, 11